A cancer pill, preferably without severe side effects, is something we'd all welcome. Is it a matter of time before such a pill is a reality? We put this question to three Leiden researchers and asked how they themselves ...
Feb 22, 2022
0
2
(HealthDay)—For patients with recurrent cervical cancer after first-line platinum-containing chemotherapy, survival is significantly longer with cemiplimab than with single-agent chemotherapy, according to a study published ...
Feb 11, 2022
0
1
Investigators from UCLA Jonsson Comprehensive Cancer Center have identified a germline biomarker signature that successfully predicts which patients will suffer serious side effects that occur in up to 3 in ten patients on ...
Feb 3, 2022
0
29
One-fifth. Nearly 20% of cancers worldwide are caused by a virus.
Feb 2, 2022
0
6
A new data portal called Cancer-Immu established by a team of Vanderbilt University Medical Center biostatisticians can help cancer clinicians and researchers predict which patients will respond to immune checkpoint inhibitors. ...
Jan 18, 2022
0
10
A study published today in Cell Reports reveals important insights into the molecular mechanisms that underpin the body's natural defenses against the development of skin cancer. The findings offer new clues into the behavior ...
Jan 11, 2022
0
72
Translocation renal cell carcinoma (tRCC) is a rare and aggressive form of kidney cancer. It accounts for about 5 percent of all renal cell carcinomas in adults and about 50 percent in children. Relatively little is known ...
Jan 10, 2022
0
24
In the United States alone, about 3.3 million people are diagnosed with basal and squamous cell cancers (skin cancers) per year. Skin cancer is still detected using visual examination, a method of limited reliability for ...
Dec 22, 2021
0
10
Cancer chemotherapy has undergone a paradigm shift in recent years with traditional treatments like broad-spectrum cytotoxic agents being complemented or replaced by drugs that target specific genes believed to drive the ...
Dec 13, 2021
0
7
In an early benefit assessment, the German Institute for Quality and Efficiency in Health Care (IQWiG) investigated whether nivolumab has an added benefit over watchful waiting in the adjuvant treatment of adults with carcinoma ...
Dec 10, 2021
0
1
